Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Sponsored by CardioDx
About this trial
Last updated 6 years ago
Study ID
CDX_000011
Status
Completed
Type
Observational
Placebo
No
Accepting
21 to 99 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 13 years ago
What is this trial about?
To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood
assay changes the diagnostic testing pattern in patients referred to a cardiologist for
the evaluation of chest pain or anginal equivalent symptoms.
What are the participation requirements?
Inclusion Criteria
1. Stable chest pain, typical or atypical angina or anginal equivalent
2. The patient has signed the appropriate Institutional Review Board approved Informed Consent Form.
Exclusion Criteria
1. History of myocardial infarction
2. Current myocardial infarct (MI) or acute coronary syndrome
3. Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms
4. Any previous coronary revascularization
5. Any individuals with:
1. Diabetes
2. Suspected unstable angina
3. Systemic infections
4. Systemic inflammatory conditions
6. Any individuals currently taking:
1. Steroids
2. Immunosuppressive agents
3. Chemotherapeutic agents
7. Recipient of any organ transplant